Bio-Techne Market Cap

Bio-Techne has a market cap or net worth of $11.37 billion as of October 19, 2026. It is the 1,939th most valuable company in the world and the 692nd biggest in the United States. Its market cap has increased by 18.14% in one year.

Market Cap

11.37B

Enterprise Value

11.39B

1-Year Change

18.14%

Global Rank

#1,939

Country Rank

#692 United States

ChartMarket Cap Chart

Chart

Since December 1, 1998, Bio-Techne's market cap has increased from $355.80M to $11.37B, an increase of 3,094.98%. That is a compound annual growth rate of 13.22%.

Market Cap History

Date	Market Cap	% Change
Oct 19, 2026	11.37B	24.06%
Dec 31, 2025	9.16B	-19.94%
Dec 31, 2024	11.45B	-6.21%
Dec 29, 2023	12.20B	-6.20%
Dec 30, 2022	13.01B	-36.00%
Dec 31, 2021	20.33B	65.81%
Dec 31, 2020	12.26B	46.55%
Dec 31, 2019	8.37B	53.07%
Dec 31, 2018	5.47B	12.61%
Dec 29, 2017	4.85B	26.50%
Dec 30, 2016	3.84B	14.62%
Dec 31, 2015	3.35B	-2.30%
Dec 31, 2014	3.43B	-1.84%
Dec 31, 2013	3.49B	38.67%
Dec 31, 2012	2.52B	-0.35%
Dec 30, 2011	2.53B	3.71%
Dec 31, 2010	2.44B	-4.63%
Dec 31, 2009	2.55B	4.09%
Dec 31, 2008	2.45B	-6.00%
Dec 31, 2007	2.61B	19.52%
Dec 29, 2006	2.18B	0.16%
Dec 30, 2005	2.18B	35.65%
Dec 31, 2004	1.61B	3.50%
Dec 31, 2003	1.55B	31.15%
Dec 31, 2002	1.18B	-22.59%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Company	Market Cap
Ascendis Pharma	14.79B
Halozyme Therapeutics	13.83B
Jazz Pharmaceuticals	13.65B
BridgeBio Pharma	12.98B
Corcept Therapeutics	11.91B
Summit Therapeutics	11.70B
BioMarin Pharmaceutical	10.58B
Madrigal Pharmaceuticals	10.39B

Market Cap Rankings